THINC® – Task Force and Cognition Tool

The THINC® Task Force comprises a global faculty with expertise in the broad areas of psychology, psychiatry, mood disorders, psychopharmacology and, specifically, in psychometrics. This team has been assembled not only because its members have done original research in the field of cognition deficits in depression but also because they have translated this research to make it accessible to the practicing clinician thereby allowing them to assess their patients with this condition for cognitive deficiencies in depression.

As Professor McIntyre explained, the overarching aim of the THINC® Task Force is to increase awareness of cognition - and cognition deficits – in depression– what is its pertinence, why assess it, why measure it and, importantly, why treat it?

Sharpening the focus on depression cognition

One of the key deliverables of the THINC® Task Force is to provide clinicians with a measurement tool that detects cognitive deficiencies in depressed patients. Professor McIntyre described this as a tool that will allow busy practitioners to ‘sharpen their focus’ on cognition.  The tool is easy to use in everyday practice and will facilitate better evaluation and management of cognitive deficiencies in depressed patients.

Contained within the THINC® Cognition Tool are a number of brief, easy to administer and easy to understand objective tests including the Digit Symbol Coding Test (DSCD), Choice Reaction Time (CRT), the Trail Making Test (TMT) and the Two-Back Test (2BT) as well as the subjective, patient reported assessment PDQ test.  As Professor McIntyre pointed out, it is critical to have both objective and subjective assessments because this combination provides both clinician and patient-based information of overall cognitive function.

The THINC® Cognition Tool along with many other useful materials concerned with cognitive deficiency in depression MDD will be available soon.

Counting the cost of cognition

It is recognised that cognitive impairment drives functional impairment. By ignoring cognitive impairment, this drives up the cost of managing not only depression but possibly other mental disorders.  Furthermore, the work force has changed and for societies to remain competitive, they have to look after and preserve the cognitive wellbeing of their citizens. By gaining a good understanding of brain substrates that underlie depression and the associated cognitive dysfunction it should be possible in the future to better target cognitive impairment as measured by the THINC® tool.

The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Le informazioni contenute nel nuovo sito prescelto possono non essere conformi al D.Ivo 219/06 che regola la pubblicità dei medicinali per uso umano e le opinioni espresse non riflettono necessariamente le posizioni dell’azienda, non sono da essa avvallate.
Accesso riservato a Operatori Sanitari
Per accedere si prega di registrarsi o, in caso sia già stato fatto, di autenticarsi
L’accesso a Progress in Mind Italia è consentito unicamente agli Operatori Sanitari (medici e farmacisti). I contenuti di questo sito sono prodotti da un team di Operatori Sanitari il cui obiettivo è presentare le ultime novità in ambito psichiatrico e neurologico, attraverso interviste, registrazioni audio/video di seminari con opinion leader, report e sintesi di congressi sia internazionali che nazionali. Per poter accedere al sito è quindi necessario registrarsi e fornire alcuni dati così da poter verificare che l‘utente sia un Operatore Sanitario.
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country